Pharma’s Defeat In Doughnut Hole Battle Possible Harbinger Of Things To Come For Powerful Industry

Despite an intense lobbying push, drugmakers weren't able to convince lawmakers to let them off the hook for beneficiaries that fall into the doughtnut hole, raising questions about the industry's current clout. Meanwhile, a drug distributor has been accused of illegally pooling leftover cancer medications to sell to providers; Norvatis is buying gene-therapy company AveXis; a powerful pharmaceutical company dabbles in vineyards; and more.

from Kaiser Health News https://ift.tt/2qj3ku0